How PSI Reduced Clinical Trial Site Identification From Weeks to Minutes With a Unified, Trusted Context Layer • Arango

PSI, a clinical research organization, built SYNETIC™ using the Arango Contextual Data Platform to unify fragmented clinical trial data across investigators, institutions, protocols, and historical outcomes. By combining graph, vector, document, and search capabilities, the platform creates a trusted, explainable context layer that enables AI-driven site recommendations. The result: clinical trial site identification dropped from six weeks to minutes, reducing non-enrolling sites and saving millions of dollars per study. The system also provides explainable AI outputs with rationale, supporting evidence, and confidence levels—critical for regulated healthcare environments.